Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ramosetron vs. ramosetron plus dexamethasone for the prevention of postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy: Prospective,

Similar presentations


Presentation on theme: "Ramosetron vs. ramosetron plus dexamethasone for the prevention of postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy: Prospective,"— Presentation transcript:

1 Ramosetron vs. ramosetron plus dexamethasone for the prevention of postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy: Prospective, randomized, and double-blind study  Jung-Hee Ryu, Ji-Eun Chang, Hye-Rim Kim, Jung-Won Hwang, Ah-Young Oh, Sang-Hwan Do  International Journal of Surgery  Volume 11, Issue 2, Pages (March 2013) DOI: /j.ijsu Copyright © 2013 Surgical Associates Ltd Terms and Conditions

2 Fig. 1 Flow diagram of patients. Seventy six patients were randomized. Three patients (2 patients from R group and 1 patient from D group) were eliminated due to conversion to open cholecytectomy and 1 patient was excluded from the analysis due to protocol violation (ondansetron administration instead of metoclopramide as a rescue antiemetic). R group; ramosetron alone group. D group: dexamethasone plus ramosetron group. International Journal of Surgery  , DOI: ( /j.ijsu ) Copyright © 2013 Surgical Associates Ltd Terms and Conditions


Download ppt "Ramosetron vs. ramosetron plus dexamethasone for the prevention of postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy: Prospective,"

Similar presentations


Ads by Google